시장보고서
상품코드
1090012

세계의 입자선 치료 시장 규모 : 유형, 제품 및 서비스, 암 유형, 지역별 예측(2022-2028년)

Global Particle Therapy Market Size study, By Type, By Product & Service, By Cancer Type, and Regional Forecasts 2022-2028

발행일: | 리서치사: Bizwit Research & Consulting LLP | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 입자선 치료 시장 규모는 2021년에 약 6억 2,569만 달러로 평가되었으며, 2022-2028년간 8.2% 이상의 성장률로 성장할 것으로 예측됩니다.

암 발증률 상승, 임상시험에서의 입자선 치료 채용 확대, 새로운 기술의 출현, 세계의 입자선 치료센터 증가 등이 시장 성장 주요인이 되고 있습니다. 그러나, 방사선 피폭 리스크 증가와 의료시설의 인프라적인 문제가 2022-2028년간 시장 성장을 방해할 전망입니다. 또한 신흥 시장에서의 입자선 치료 수요 증가와 의료비 증가가 예측 기간에 시장 수요를 자극할 것으로 예측됩니다.

세계의 입자선 치료(Particle Therapy) 시장에 대해 조사분석했으며, 시장 동향, 경쟁 구도, 부문별/지역별 시장 분석, 주요 기업 프로파일 등의 정보를 제공합니다.

목차

제1장 개요

제2장 세계의 입자선 치료 시장 정의와 범위

제3장 세계의 입자선 치료 시장 역학

  • 입자선 치료 시장 영향 분석(2020-2028년)

제4장 세계의 입자선 치료 시장 업계 분석

  • Porter's Five Forces 모델
  • PEST 분석
  • 투자 채용 모델
  • 애널리스트의 추천 사항과 결론
  • 주요 투자 기회
  • 주요 성공 전략

제5장 리스크 평가 : COVID-19의 영향

    • 업계에 대한 COVID-19의 전체적인 영향 평가
    • COVID-19 이전 및 COVID-19 이후의 시장 시나리오

제6장 세계의 입자선 치료 시장 : 유형별

  • 시장 현황
  • 시장 실적과 가능성 분석 : 유형별
  • 시장 추산과 예측 : 유형별
    • 양자선 치료
    • 중이온 요법

제7장 세계의 입자선 치료 시장 : 제품 및 서비스별

  • 시장 현황
  • 시장 실적과 가능성 분석 : 제품 및 서비스별
  • 시장 추산과 예측 : 제품 및 서비스별(2018-2028년)
  • 하위 부문 분석
    • 제품
    • 서비스

제8장 세계의 입자선 치료 시장 : 암 유형별

  • 시장 현황
  • 시장 실적과 가능성 분석 : 암 유형별
  • 시장 추산과 예측 : 암 유형별(2018-2028년)
  • 하위 부문 분석
    • 소아암
    • 전립선암
    • 폐암
    • 유방암
    • 두경부암
    • 기타 암

제9장 세계의 입자선 치료 시장 : 지역 분석

  • 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
  • 기타 지역

제10장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Varian Medical Systems, Inc.
    • Hitachi, Ltd.
    • Sumitomo Heavy Industries, Ltd.
    • Danfysik A/S
    • Hitachi, Ltd
    • Ion Beam Applications Sa(IBA)
    • Mevion Medical Systems, Inc.
    • Optivus Proton Therapy, Inc.
    • ProTom International, Inc.
    • Provision Healthcare, LLC
    • Sumitomo Heavy Industries, Ltd.

제11장 조사 프로세스

LSH 22.07.04

Global Particle Therapy Market is valued at approximately USD 625.69 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.2% over the forecast period 2022-2028. Particle therapy is a type of external beam radiotherapy that uses beams of energetic protons, neutrons, or any other heavy positive ions to cure cancer. Factors such as increasing incidences of cancer, rising adoption of particle therapy in clinical trials, the advent of novel technologies, and a growing number of particle therapy centers worldwide are the primarily attributing to the growth of the market. For instance, according to the National Cancer Institute, in 2018, the total number of cancer patients is accounted for 18.1 million cases and the figure is projected to rise and likely to reach 29.5 million cases. Consequentially, the rising prevalence of cancer is fueling the demand for Particle Therapy, which, in turn, accelerates the market growth across the globe. However, the growing risk of exposure to radiation and infrastructural challenges in healthcare facilities impede the growth of the market over the forecast period of 2022-2028. Also, increasing demand for particle therapy in emerging markets and growing healthcare expenditure are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Particle Therapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the presence of the huge patient pool and growing initiatives to promote the adoption of advanced particle therapy technologies. Whereas, North America is anticipated to exhibit a substantial growth rate over the forecast period 2022-2028. Factors such as the rising preference for particle therapy owing to the various benefits offered compared to other procedures, as well as, the availability of favorable reimbursement scenarios, would create lucrative growth prospects for the Particle Therapy Market across the North American region.

Major market players included in this report are:

Varian Medical Systems, Inc.

Hitachi, Ltd.

Sumitomo Heavy Industries, Ltd.

Danfysik A/S

Hitachi, Ltd

Ion Beam Applications Sa (IBA)

Mevion Medical Systems, Inc.

Optivus Proton Therapy, Inc.

ProTom International, Inc.

Provision Healthcare, LLC

Sumitomo Heavy Industries, Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Proton Therapy

Heavy Ion Therapy

By Product & Service:

Products

Services

By Cancer Type:

Pediatric Cancer

Prostate Cancer

Lung Cancer

Breast Cancer

Head and Neck Cancer

Other Cancers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Particle Therapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Particle Therapy Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Particle Therapy Market, by Type, 2020-2028 (USD Million)
    • 1.2.3. Particle Therapy Market, by Product & Service, 2020-2028 (USD Million)
    • 1.2.4. Particle Therapy Market, by Cancer Type, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Particle Therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Particle Therapy Market Dynamics

  • 3.1. Particle Therapy Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidences of cancer
      • 3.1.1.2. Rising adoption of particle therapy in clinical trials
    • 3.1.2. Market Challenges
      • 3.1.2.1. Growing risk for the exposure to radiation
      • 3.1.2.2. Infrastructural challenges in healthcare facilities
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing demand for particle therapy in emerging markets
      • 3.1.3.2. Growing healthcare expenditure

Chapter 4. Global Particle Therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Particle Therapy Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Particle Therapy Market by Type, Performance - Potential Analysis
  • 6.3. Global Particle Therapy Market Estimates & Forecasts by Type, 2018-2028 (USD Million)
  • 6.4. Particle Therapy Market, Sub Segment Analysis
    • 6.4.1. Proton Therapy
    • 6.4.2. Heavy Ion Therapy

Chapter 7. Global Particle Therapy Market, by Product & Service

  • 7.1. Market Snapshot
  • 7.2. Global Particle Therapy Market by Product & Service, Performance - Potential Analysis
  • 7.3. Global Particle Therapy Market Estimates & Forecasts by Product & Service, 2018-2028 (USD Million)
  • 7.4. Particle Therapy Market, Sub Segment Analysis
    • 7.4.1. Products
    • 7.4.2. Services

Chapter 8. Global Particle Therapy Market, by Cancer Type

  • 8.1. Market Snapshot
  • 8.2. Global Particle Therapy Market by Cancer Type, Performance - Potential Analysis
  • 8.3. Global Particle Therapy Market Estimates & Forecasts by Cancer Type, 2018-2028 (USD Million)
  • 8.4. Particle Therapy Market, Sub Segment Analysis
    • 8.4.1. Pediatric Cancer
    • 8.4.2. Prostate Cancer
    • 8.4.3. Lung Cancer
    • 8.4.4. Breast Cancer
    • 8.4.5. Head and Neck Cancer
    • 8.4.6. Other Cancers

Chapter 9. Global Particle Therapy Market, Regional Analysis

  • 9.1. Particle Therapy Market, Regional Market Snapshot
  • 9.2. North America Particle Therapy Market
    • 9.2.1. U.S. Particle Therapy Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Product & Service breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. Cancer Type breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Particle Therapy Market
  • 9.3. Europe Particle Therapy Market Snapshot
    • 9.3.1. U.K. Particle Therapy Market
    • 9.3.2. Germany Particle Therapy Market
    • 9.3.3. France Particle Therapy Market
    • 9.3.4. Spain Particle Therapy Market
    • 9.3.5. Italy Particle Therapy Market
    • 9.3.6. Rest of Europe Particle Therapy Market
  • 9.4. Asia-Pacific Particle Therapy Market Snapshot
    • 9.4.1. China Particle Therapy Market
    • 9.4.2. India Particle Therapy Market
    • 9.4.3. Japan Particle Therapy Market
    • 9.4.4. Australia Particle Therapy Market
    • 9.4.5. South Korea Particle Therapy Market
    • 9.4.6. Rest of Asia Pacific Particle Therapy Market
  • 9.5. Latin America Particle Therapy Market Snapshot
    • 9.5.1. Brazil Particle Therapy Market
    • 9.5.2. Mexico Particle Therapy Market
  • 9.6. Rest of The World Particle Therapy Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Varian Medical Systems, Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Hitachi, Ltd.
    • 10.2.3. Sumitomo Heavy Industries, Ltd.
    • 10.2.4. Danfysik A/S
    • 10.2.5. Hitachi, Ltd
    • 10.2.6. Ion Beam Applications Sa (IBA)
    • 10.2.7. Mevion Medical Systems, Inc.
    • 10.2.8. Optivus Proton Therapy, Inc.
    • 10.2.9. ProTom International, Inc.
    • 10.2.10. Provision Healthcare, LLC
    • 10.2.11. Sumitomo Heavy Industries, Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제